PDE is a treatable disorder of lysine metabolism
Image credit: GMDI
Abstract
This talk will focus on the impact of lysine reduction therapies (LRT) on cognitive outcomes and the current consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy (PDE-ALDH7A1).
Date
Oct 7, 2021 1:00 PM
Location
Virtual lecture
Curtis R. Coughlin II
Associate Professor
My research interests include inborn errors of metabolism that impact neurologic function with a focus on pyridoxine-dependent epilepsy, glutaric aciduria I, and vitamin B6 metabolism.